Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

S. Mitsunaga, M. Ikeda, S. Shimizu, I. Ohno, J. Furuse, M. Inagaki, S. Higashi, H. Kato, K. Terao, A. Ochiai

Research output: Contribution to journalArticlepeer-review

91 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences